Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients - Eggink, F.A.; Mom, C.H.; Boll, D.; Ezendam, N.P.M.; Kruitwagen, R.F.P.M.; Pijnenborg, J.M.A.; van der Aa, M.A.; Nijman, H.W. (Gynecologic oncology, 2017)
Keywords: Adenocarcinoma, Clear Cell - pathology; Adenocarcinoma, Clear Cell - therapy; Adjuvant therapy; Adult; Aged; Aged, 80 and over; Carcinoma, Endometrioid - pathology; Carcinoma, Endometrioid - therapy; Chemotherapy, Adjuvant - utilization; Compliance; Endometrial cancer; Endometrial Neoplasms - pathology; Endometrial Neoplasms - therapy; Female; Guideline Adherence - statistics & numerical data; Guidelines; Hematology, Oncology and Palliative Medicine; High risk; Humans; Hysterectomy; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous - pathology; Neoplasms, Cystic, Mucinous, and Serous - therapy; Netherlands; Obstetrics and Gynecology; Overall survival; Practice Guidelines as Topic; Quality Improvement; Radiotherapy, Adjuvant - utilization; Registries; Risk; High risk; Endometrial cancer; Compliance; Overall survival; Adjuvant therapy; Guidelines